A retrospective, cross-sectional study assessing prevalence of sexual dysfunction in a cohort of patients with moderate-to-severe atopic dermatitis and impact of dupilumab therapy on it
Latest Information Update: 05 May 2022
At a glance
- Drugs Dupilumab (Primary)
- Indications Atopic dermatitis
- Focus Therapeutic Use
Most Recent Events
- 05 May 2022 New trial record
- 01 May 2022 Results published in the International Journal of Dermatology